Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MUR | new code | 28/11/08 | 0 | 867 | |||
|
|||||||
MUR | sus ? | 27/11/08 | 0 | 253 | |||
|
|||||||
MUR | 9 74 million crossed | 27/11/08 | 0 | 356 | |||
|
|||||||
MUR | Ann: Results of Annual General Meeting | 25/11/08 | 0 | 605 | |||
|
|||||||
MUR | 2 mil buy just before close | 21/11/08 | 0 | 410 | |||
|
|||||||
MUR | some strange trading | 10/11/08 | 6 | 1.4K | |||
|
|||||||
MUR | broker note fairfax london | 27/10/08 | 0 | 529 | |||
|
|||||||
MUR | hello | 18/10/08 | 1 | 675 | |||
|
See All Discussions